Combination of Cisplatin and Melatonin on the Inhibition of Cisplatin Resistance in SKOV3 Cells
Published: 3 January 2023| Version 1 | DOI: 10.17632/ftdpsfwrtv.1
Contributor:
Cut Adeya AdellaDescription
This data shows about outcome of flowcytometry for the variables (CTR-1, Pgp, E-Cadherin, GSH, ERCC1, and Annexin V for all the study groups including the combination of melatonin and cisplatin groups
Files
Steps to reproduce
We used experiment laboratory design using combination of cisplatin and melatonin in cisplatin-resistant ovarian cancer cell was conducted using SKOV3. Cell was cultured and harvested, MTS assay was used for cell viability and flowcytometry for the study.
Institutions
Universitas Sumatera Utara
Categories
Cancer Treatment, Gynecological Oncology